Exact Mass: 569.238971
Exact Mass Matches: 569.238971
Found 500 metabolites which its exact mass value is equals to given mass value 569.238971
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Decarbamoylnovobiocin
A hydroxycoumarin that is novobiocin lacking the carbamoyl group from position 3 on the hexose ring.
Aklavin
D000970 - Antineoplastic Agents D007155 - Immunologic Factors
Leuphasyl
Aklavin
Ibritumomab tiuxetan
(2S)-3-(1H-Indol-3-yl)-N-[[1-(4-methoxyphenyl)cyclohexyl]methyl]-2-[(4-nitrophenyl)carbamoylamino]propanamide
Ala Phe Phe Trp
Ala Phe Trp Phe
Ala Met Trp Tyr
Ala Met Tyr Trp
Ala Trp Phe Phe
Ala Trp Met Tyr
Ala Trp Tyr Met
Ala Tyr Met Trp
Ala Tyr Trp Met
Cys Asp Phe Trp
Cys Asp Trp Phe
Cys Glu Arg Tyr
Cys Glu Tyr Arg
Cys Phe Asp Trp
Cys Phe Trp Asp
Cys Arg Glu Tyr
Cys Arg Tyr Glu
Cys Val Trp Tyr
Cys Val Tyr Trp
Cys Trp Asp Phe
Cys Trp Phe Asp
Cys Trp Val Tyr
Cys Trp Tyr Val
Cys Tyr Glu Arg
Cys Tyr Arg Glu
Cys Tyr Val Trp
Cys Tyr Trp Val
Asp Cys Phe Trp
Asp Cys Trp Phe
Asp Phe Cys Trp
Asp Phe Trp Cys
Asp His Ile Trp
Asp His Leu Trp
Asp His Trp Ile
Asp His Trp Leu
Asp Ile His Trp
Asp Ile Trp His
Asp Leu His Trp
Asp Leu Trp His
Asp Ser Trp Tyr
Asp Ser Tyr Trp
Asp Trp Cys Phe
Asp Trp Phe Cys
Asp Trp His Ile
Asp Trp His Leu
Asp Trp Ile His
Asp Trp Leu His
Asp Trp Ser Tyr
Asp Trp Tyr Ser
Asp Tyr Ser Trp
Asp Tyr Trp Ser
Glu Cys Arg Tyr
Glu Cys Tyr Arg
Glu Glu His Arg
Glu Glu Arg His
Glu Phe Phe Lys
Glu Phe Phe Gln
Glu Phe Lys Phe
Glu Phe Gln Phe
Glu His Glu Arg
Glu His Arg Glu
Glu His Val Trp
Glu His Trp Val
Glu Lys Phe Phe
Glu Lys Met Tyr
Glu Lys Tyr Met
Glu Met Lys Tyr
Glu Met Gln Tyr
Glu Met Tyr Lys
Glu Met Tyr Gln
Glu Gln Phe Phe
Glu Gln Met Tyr
Glu Gln Tyr Met
Glu Arg Cys Tyr
Glu Arg Glu His
Glu Arg His Glu
Glu Arg Tyr Cys
Glu Val His Trp
Glu Val Trp His
Glu Trp His Val
Glu Trp Val His
Glu Tyr Cys Arg
Glu Tyr Lys Met
Glu Tyr Met Lys
Glu Tyr Met Gln
Glu Tyr Gln Met
Glu Tyr Arg Cys
Phe Ala Phe Trp
Phe Ala Trp Phe
Phe Cys Asp Trp
Phe Cys Trp Asp
Phe Asp Cys Trp
Phe Asp Trp Cys
Phe Glu Phe Lys
Phe Glu Phe Gln
Phe Glu Lys Phe
Phe Glu Gln Phe
Phe Phe Ala Trp
Phe Phe Glu Lys
Phe Phe Glu Gln
Phe Phe Gln Glu
Phe Phe Trp Ala
Phe Met Ser Trp
Phe Met Trp Ser
Phe Gln Glu Phe
Phe Gln Phe Glu
Phe Ser Met Trp
Phe Ser Trp Met
Phe Trp Ala Phe
Phe Trp Cys Asp
Phe Trp Asp Cys
Phe Trp Phe Ala
Phe Trp Met Ser
Phe Trp Ser Met
His Asp Ile Trp
His Asp Leu Trp
His Asp Trp Ile
His Asp Trp Leu
His Glu Glu Arg
His Glu Arg Glu
His Glu Val Trp
His Glu Trp Val
His His Asn Tyr
His His Tyr Asn
His Ile Asp Trp
His Ile Trp Asp
His Leu Asp Trp
His Leu Trp Asp
His Met Pro Trp
His Met Trp Pro
His Asn His Tyr
His Asn Asn Trp
His Asn Trp Asn
His Asn Tyr His
His Pro Met Trp
His Pro Trp Met
His Arg Glu Glu
His Val Glu Trp
His Val Trp Glu
His Trp Asp Ile
His Trp Asp Leu
His Trp Glu Val
His Trp Ile Asp
His Trp Leu Asp
His Trp Met Pro
His Trp Asn Asn
His Trp Pro Met
His Trp Val Glu
His Tyr His Asn
His Tyr Asn His
Ile Asp His Trp
Ile Asp Trp His
Ile His Asp Trp
Ile His Trp Asp
Ile Trp Asp His
Ile Trp His Asp
Lys Glu Met Tyr
Lys Glu Tyr Met
Lys Met Glu Tyr
Lys Met Tyr Glu
Lys Tyr Glu Met
Lys Tyr Met Glu
Leu Asp His Trp
Leu Asp Trp His
Leu His Asp Trp
Leu His Trp Asp
Leu Trp Asp His
Leu Trp His Asp
Met Ala Trp Tyr
Met Ala Tyr Trp
Met Glu Lys Tyr
Met Glu Gln Tyr
Met Glu Tyr Lys
Met Glu Tyr Gln
Met Phe Ser Trp
Met Phe Trp Ser
Met His Pro Trp
Met His Trp Pro
Met Lys Glu Tyr
Met Lys Tyr Glu
Met Pro His Trp
Met Pro Trp His
Met Gln Glu Tyr
Met Gln Tyr Glu
Met Arg Thr Tyr
Met Arg Tyr Thr
Met Ser Phe Trp
Met Ser Trp Phe
Met Thr Arg Tyr
Met Thr Tyr Arg
Met Trp Ala Tyr
Met Trp Phe Ser
Met Trp His Pro
Met Trp Pro His
Met Trp Ser Phe
Met Trp Tyr Ala
Met Tyr Ala Trp
Met Tyr Glu Lys
Met Tyr Glu Gln
Met Tyr Lys Glu
Met Tyr Gln Glu
Met Tyr Arg Thr
Met Tyr Thr Arg
Met Tyr Trp Ala
Asn His His Tyr
Asn His Asn Trp
Asn His Trp Asn
Asn His Tyr His
Asn Asn His Trp
Asn Asn Trp His
Asn Trp His Asn
Asn Trp Asn His
Asn Tyr His His
Pro His Met Trp
Pro His Trp Met
Pro Met His Trp
Pro Met Trp His
Pro Gln Tyr Tyr
Pro Trp His Met
Pro Trp Met His
Pro Tyr Gln Tyr
Pro Tyr Tyr Gln
Gln Glu Phe Phe
Gln Glu Met Tyr
Gln Glu Tyr Met
Gln Phe Glu Phe
Gln Phe Phe Glu
Gln Met Glu Tyr
Gln Met Tyr Glu
Gln Pro Tyr Tyr
Gln Tyr Glu Met
Gln Tyr Met Glu
Gln Tyr Pro Tyr
Gln Tyr Tyr Pro
Arg Cys Glu Tyr
Arg Cys Tyr Glu
Arg Glu Cys Tyr
Arg Glu Glu His
Arg Glu His Glu
Arg Glu Tyr Cys
Arg His Glu Glu
Arg Met Thr Tyr
Arg Met Tyr Thr
Arg Thr Met Tyr
Arg Thr Tyr Met
Arg Tyr Cys Glu
Arg Tyr Glu Cys
Arg Tyr Met Thr
Arg Tyr Thr Met
Ser Asp Trp Tyr
Ser Asp Tyr Trp
Ser Phe Met Trp
Ser Phe Trp Met
Ser Met Phe Trp
Ser Met Trp Phe
Ser Trp Asp Tyr
Ser Trp Phe Met
Ser Trp Met Phe
Ser Trp Tyr Asp
Ser Tyr Asp Trp
Ser Tyr Trp Asp
Thr Met Arg Tyr
Thr Met Tyr Arg
Thr Arg Met Tyr
Thr Arg Tyr Met
Thr Thr Trp Tyr
Thr Thr Tyr Trp
Thr Trp Thr Tyr
Thr Trp Tyr Thr
Thr Tyr Met Arg
Thr Tyr Arg Met
Thr Tyr Thr Trp
Thr Tyr Trp Thr
Val Cys Trp Tyr
Val Cys Tyr Trp
Val Glu His Trp
Val Glu Trp His
Val His Glu Trp
Val His Trp Glu
Val Trp Cys Tyr
Val Trp Glu His
Val Trp His Glu
Val Trp Tyr Cys
Val Tyr Cys Trp
Val Tyr Trp Cys
Trp Ala Phe Phe
Trp Ala Met Tyr
Trp Ala Tyr Met
Trp Cys Asp Phe
Trp Cys Phe Asp
Trp Cys Val Tyr
Trp Cys Tyr Val
Trp Asp Cys Phe
Trp Asp Phe Cys
Trp Asp His Ile
Trp Asp His Leu
Trp Asp Ile His
Trp Asp Leu His
Trp Asp Ser Tyr
Trp Asp Tyr Ser
Trp Glu His Val
Trp Glu Val His
Trp Phe Ala Phe
Trp Phe Cys Asp
Trp Phe Asp Cys
Trp Phe Phe Ala
Trp Phe Met Ser
Trp Phe Ser Met
Trp His Asp Ile
Trp His Asp Leu
Trp His Glu Val
Trp His Ile Asp
Trp His Leu Asp
Trp His Met Pro
Trp His Asn Asn
Trp His Pro Met
Trp His Val Glu
Trp Ile Asp His
Trp Ile His Asp
Trp Leu Asp His
Trp Leu His Asp
Trp Met Ala Tyr
Trp Met Phe Ser
Trp Met His Pro
Trp Met Pro His
Trp Met Ser Phe
Trp Met Tyr Ala
Trp Asn His Asn
Trp Asn Asn His
Trp Pro His Met
Trp Pro Met His
Trp Ser Asp Tyr
Trp Ser Phe Met
Trp Ser Met Phe
Trp Ser Tyr Asp
Trp Thr Thr Tyr
Trp Thr Tyr Thr
Trp Val Cys Tyr
Trp Val Glu His
Trp Val His Glu
Trp Val Tyr Cys
Trp Tyr Ala Met
Trp Tyr Cys Val
Trp Tyr Asp Ser
Trp Tyr Met Ala
Trp Tyr Ser Asp
Trp Tyr Thr Thr
Trp Tyr Val Cys
Tyr Ala Met Trp
Tyr Ala Trp Met
Tyr Cys Glu Arg
Tyr Cys Arg Glu
Tyr Cys Val Trp
Tyr Cys Trp Val
Tyr Asp Ser Trp
Tyr Asp Trp Ser
Tyr Glu Cys Arg
Tyr Glu Lys Met
Tyr Glu Met Lys
Tyr Glu Met Gln
Tyr Glu Gln Met
Tyr Glu Arg Cys
Tyr His His Asn
Tyr His Asn His
Tyr Lys Glu Met
Tyr Lys Met Glu
Tyr Met Ala Trp
Tyr Met Glu Lys
Tyr Met Glu Gln
Tyr Met Lys Glu
Tyr Met Gln Glu
Tyr Met Arg Thr
Tyr Met Thr Arg
Tyr Met Trp Ala
Tyr Asn His His
Tyr Pro Gln Tyr
Tyr Pro Tyr Gln
Tyr Gln Glu Met
Tyr Gln Met Glu
Tyr Gln Pro Tyr
Tyr Gln Tyr Pro
Tyr Arg Cys Glu
Tyr Arg Glu Cys
Tyr Arg Met Thr
Tyr Arg Thr Met
Tyr Ser Asp Trp
Tyr Ser Trp Asp
Tyr Thr Met Arg
Tyr Thr Arg Met
Tyr Thr Thr Trp
Tyr Thr Trp Thr
Tyr Val Cys Trp
Tyr Val Trp Cys
Tyr Trp Ala Met
Tyr Trp Cys Val
Tyr Trp Asp Ser
Tyr Trp Met Ala
Tyr Trp Ser Asp
Tyr Trp Thr Thr
Tyr Trp Val Cys
Tyr Tyr Pro Gln
Tyr Tyr Gln Pro
PS(22:6(4Z,7Z,10Z,13Z,16Z,19Z)/0:0)
5-O-[BIS(4-METHOXYPHENYL)PHENYLMETHYL]-ADENOSINE
5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-adenosine is an adenosine analog. Adenosine analogs mostly act as smooth muscle vasodilators and have also been shown to inhibit cancer progression. Its popular products are adenosine phosphate, Acadesine (HY-13417), Clofarabine (HY-A0005), Fludarabine phosphate (HY-B0028) and Vidarabine (HY-B0277)[1].
2,3,5-Tri-O-benzyl-D-arabinofuranose 1-(4-nitrobenzoate)
Bosentan hydrate
D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents D065128 - Endothelin Receptor Antagonists C28313 - Endothelin Receptor Antagonist Bosentan hydrate is a competitive and dual antagonist of endothelin-1 (ET) for the ETA and ETB receptors with Ki of 4.7 nM and 95 nM in human SMC, respectively.
2,3,5-TRI-O-BENZYL-1-O-(4-NITROBENZOYL)-D-ALPHA-ARABINOFURANOSE
N-2-(4-Benzyloxy-3-methoxyphenethyl)-4-benzyloxy-3-ethoxycarbonyloxyphenylacetamide
TERT-BUTYL 4-((6-(2-(QUINOXALINE-2-CARBOXAMIDO)PHENYL)IMIDAZO[2,1-B]THIAZOL-3-YL)METHYL)PIPERAZINE-1-CARBOXYLATE
Eluxadoline
A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07D - Antipropulsives > A07DA - Antipropulsives C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist D005765 - Gastrointestinal Agents
(1R,2R,4S)-2-ethyl-2,7-dihydroxy-1-(methoxycarbonyl)-6,11-dioxo-4-{[2,3,6-trideoxy-3-(dimethylazaniumyl)-alpha-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracen-5-olate
N-[(2S,3S)-2-[[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
4,6-dideoxy-4-[(3-hydroxy-3-methylbutanoyl)amino]-2-O-methyl-beta-D-glucopyranosyl-(1->3)-6-deoxy-alpha-L-mannopyranosyl-(1->3)-6-deoxy-alpha-L-mannopyranose
2-[(1R,8S,14R,15R)-11-hydroxy-15-[(E,2S)-2-hydroxy-3-oxooct-6-enyl]-14-[(E)-oct-6-enyl]-3,5,9-trioxo-4,10-dioxatetracyclo[9.4.0.02,6.08,12]pentadeca-2(6),12-dien-8-yl]acetate
1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[3-(trifluoromethyl)phenyl]urea
1-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[3-(trifluoromethyl)phenyl]urea
1-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[3-(trifluoromethyl)phenyl]urea
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
1-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[3-(trifluoromethyl)phenyl]urea
1-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[2-(trifluoromethyl)phenyl]urea
1-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[2-(trifluoromethyl)phenyl]urea
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[4-(trifluoromethyl)phenyl]carbamoylamino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N-(2-pyridin-4-ylethyl)-4-(3-pyridin-3-ylphenyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N-(2-pyridin-4-ylethyl)-4-(3-pyridin-4-ylphenyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[3-(trifluoromethyl)phenyl]urea
N-[(2R,3S)-2-[[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
N-[(2S,3S)-2-[[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
N-[(2S,3R)-2-[[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
1-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[3-(trifluoromethyl)phenyl]urea
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N-(2-pyridin-4-ylethyl)-4-(3-pyridin-4-ylphenyl)-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
1-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[2-(trifluoromethyl)phenyl]urea
1-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[2-(trifluoromethyl)phenyl]urea
N-[(2R,3R)-2-[[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
N-[(2R,3S)-2-[[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
N-[(2S,3R)-2-[[[[(3,5-dimethyl-4-isoxazolyl)amino]-oxomethyl]-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-4,4,4-trifluorobutanamide
1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[2-(trifluoromethyl)phenyl]urea
1-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[2-(trifluoromethyl)phenyl]urea
1-[[(10R,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11-methyl-14-oxo-9-oxa-13-azatricyclo[13.4.0.02,7]nonadeca-1(19),2,4,6,15,17-hexaen-10-yl]methyl]-1-methyl-3-[3-(trifluoromethyl)phenyl]urea
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(1S)-1-phenylethyl]acetamide
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-phenylethyl)acetamide
(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-N-(2-pyridin-4-ylethyl)-4-[3-(3-pyridinyl)phenyl]-1,3-dihydropyrrolo[3,4-c]pyridine-6-carboxamide
2-amino-3-[[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-hydroxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
4,7-DI(4-Butoxyphenyl)-6-(3,4-dimethoxyphenyl)-1,2,5-thiadiazolo(3,4-C)pyridine
aclacinomycin T zwitterion
A zwitterion obtained by transfer of a proton from the 5-hydroxy to the tertiary amino group of aclacinomycin T. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
8,12-diethyl-3-vinylbacteriochlorophyllide d(1-)
A cyclic tetrapyrrole anion that is the conjugate base of 8,12-diethyl-3-vinylbacteriochlorophyllide d, obtained by deprotonation of the carboxy group; major species at pH 7.3.
beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosaminyl group
The group obtained by removal of the anomeric hydroxyl group from beta-D-galactosyl-1,3-(N-acetyl-beta-D-glucosaminyl-1,6)-N-acetyl-D-galactosamine.
Aclacinomycin T
An anthracycline that is aklavinone having an alpha-L-rhodosaminyl residue attached at position 4 via a glycosidic linkage.
BI-882370
BI-882370 is a potent and selective RAF kinase inhibitor that binds to the ATP binding site of the kinase positioned in the DFG-out (inactive) conformation of the BRAF kinase. BI-882370 (BI 882370) inhibits the oncogenic BRAFV600E-mutant, the WT BRAF and CRAF kinases with IC50s of 0.4, 0.8, and 0.6 nM, respectively. BI-882370 also inhibits SRC family kinases[1].